BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 27354093)

  • 1. Evaluation of [
    Savolainen H; Windhorst AD; Elsinga PH; Cantore M; Colabufo NA; Willemsen AT; Luurtsema G
    J Cereb Blood Flow Metab; 2017 Apr; 37(4):1286-1298. PubMed ID: 27354093
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    García-Varela L; Rodríguez-Pérez M; Custodia A; Moraga-Amaro R; Colabufo NA; Aguiar P; Sobrino T; Dierckx RAJO; van Waarde A; Elsinga PH; Luurtsema G
    Mol Pharm; 2021 Aug; 18(8):3073-3085. PubMed ID: 34228458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic Modeling of [
    García-Varela L; Arif WM; Vállez García D; Kakiuchi T; Ohba H; Harada N; Tago T; Elsinga PH; Tsukada H; Colabufo NA; Dierckx RAJO; van Waarde A; Toyohara J; Boellaard R; Luurtsema G
    Mol Pharm; 2020 Sep; 17(9):3477-3486. PubMed ID: 32787277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of P-glycoprotein function at the human blood-brain barrier using [
    Mossel P; Arif WM; De Souza GS; Varela LG; van der Weijden CWJ; Boersma HH; Willemsen ATM; Boellaard R; Elsinga PH; Borra RJH; Dierckx RAJO; Lammertsma AA; Bartels AL; Luurtsema G
    Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):3917-3927. PubMed ID: 37552369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MC225, a Novel Probe for P-glycoprotein PET Imaging at the Blood-brain Barrier: In Vitro Cardiovascular Safety Evaluation.
    Fusi F; Durante M; Gorelli B; Perrone MG; Colabufo NA; Saponara S
    J Cardiovasc Pharmacol; 2017 Dec; 70(6):405-410. PubMed ID: 28877068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and Preclinical Evaluation of Three Novel Fluorine-18 Labeled Radiopharmaceuticals for P-Glycoprotein PET Imaging at the Blood-Brain Barrier.
    Savolainen H; Cantore M; Colabufo NA; Elsinga PH; Windhorst AD; Luurtsema G
    Mol Pharm; 2015 Jul; 12(7):2265-75. PubMed ID: 26043236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Head-to-head comparison of (R)-[
    García-Varela L; Vállez García D; Aguiar P; Kakiuchi T; Ohba H; Harada N; Nishiyama S; Tago T; Elsinga PH; Tsukada H; Colabufo NA; Dierckx RAJO; van Waarde A; Toyohara J; Boellaard R; Luurtsema G
    Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4307-4317. PubMed ID: 34117508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-response assessment of cerebral P-glycoprotein inhibition in vivo with [
    Garcia-Varela L; Mossel P; Aguiar P; Vazquez-Matias DA; van Waarde A; Willemsen ATM; Bartels AL; Colabufo NA; Dierckx RAJO; Elsinga PH; Luurtsema G
    J Control Release; 2022 Jul; 347():500-507. PubMed ID: 35588934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and Evaluation of New Fluorine-18 Labeled Verapamil Analogs To Investigate the Function of P-Glycoprotein in the Blood-Brain Barrier.
    Raaphorst RM; Luurtsema G; Schuit RC; Kooijman EJM; Elsinga PH; Lammertsma AA; Windhorst AD
    ACS Chem Neurosci; 2017 Sep; 8(9):1925-1936. PubMed ID: 28650628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiosynthesis and in vivo evaluation of 1-[18F]fluoroelacridar as a positron emission tomography tracer for P-glycoprotein and breast cancer resistance protein.
    Dörner B; Kuntner C; Bankstahl JP; Wanek T; Bankstahl M; Stanek J; Müllauer J; Bauer F; Mairinger S; Löscher W; Miller DW; Chiba P; Müller M; Erker T; Langer O
    Bioorg Med Chem; 2011 Apr; 19(7):2190-8. PubMed ID: 21419632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and in vivo evaluation of ¹⁸F-fluoroethyl GF120918 and XR9576 as positron emission tomography probes for assessing the function of drug efflux transporters.
    Kawamura K; Yamasaki T; Konno F; Yui J; Hatori A; Yanamoto K; Wakizaka H; Ogawa M; Yoshida Y; Nengaki N; Fukumura T; Zhang MR
    Bioorg Med Chem; 2011 Jan; 19(2):861-70. PubMed ID: 21185730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First clinical assessment of [
    Toyohara J; Sakata M; Ishibashi K; Mossel P; Imai M; Wagatsuma K; Tago T; Imabayashi E; Colabufo NA; Luurtsema G; Ishii K
    Ann Nucl Med; 2021 Nov; 35(11):1240-1252. PubMed ID: 34368924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of P-Glycoprotein Inhibition or Deficiency at the Blood-Brain Barrier on (18)F-2-Fluoro-2-Deoxy-D-glucose ( (18)F-FDG) Brain Kinetics.
    Tournier N; Saba W; Goutal S; Gervais P; Valette H; Scherrmann JM; Bottlaender M; Cisternino S
    AAPS J; 2015 May; 17(3):652-9. PubMed ID: 25716150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Test-Retest Repeatability of [
    García-Varela L; Vállez García D; Rodríguez-Pérez M; van Waarde A; Sijbesma JWA; Schildt A; Kwizera C; Aguiar P; Sobrino T; Dierckx RAJO; Elsinga PH; Luurtsema G
    ACS Chem Neurosci; 2020 Feb; 11(4):648-658. PubMed ID: 31961646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of dopamine D3 receptor antagonist 11C-GR218231 as PET tracer for P-glycoprotein.
    de Vries EF; Kortekaas R; van Waarde A; Dijkstra D; Elsinga PH; Vaalburg W
    J Nucl Med; 2005 Aug; 46(8):1384-92. PubMed ID: 16085598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging the Impact of the P-Glycoprotein (ABCB1) Function on the Brain Kinetics of Metoclopramide.
    Pottier G; Marie S; Goutal S; Auvity S; Peyronneau MA; Stute S; Boisgard R; Dollé F; Buvat I; Caillé F; Tournier N
    J Nucl Med; 2016 Feb; 57(2):309-14. PubMed ID: 26585058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of (R)-[11C]verapamil as PET tracer of P-glycoprotein function in the blood-brain barrier: kinetics and metabolism in the rat.
    Luurtsema G; Molthoff CF; Schuit RC; Windhorst AD; Lammertsma AA; Franssen EJ
    Nucl Med Biol; 2005 Jan; 32(1):87-93. PubMed ID: 15691665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Positron Emission Tomography Radiotracers for the GABA Transporter 1.
    Sowa AR; Brooks AF; Shao X; Henderson BD; Sherman P; Arteaga J; Stauff J; Lee AC; Koeppe RA; Scott PJH; Kilbourn MR
    ACS Chem Neurosci; 2018 Nov; 9(11):2767-2773. PubMed ID: 29763549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [¹¹C]befloxatone brain kinetics is not influenced by Bcrp function at the blood-brain barrier: a PET study using Bcrp TGEM knockout rats.
    Hosten B; Boisgard R; Jacob A; Goutal S; Saubaméa B; Dollé F; Scherrmann JM; Cisternino S; Tournier N
    Eur J Pharm Sci; 2013 Nov; 50(3-4):520-5. PubMed ID: 23981334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P-Glycoprotein (ABCB1) Inhibits the Influx and Increases the Efflux of
    Auvity S; Caillé F; Marie S; Wimberley C; Bauer M; Langer O; Buvat I; Goutal S; Tournier N
    J Nucl Med; 2018 Oct; 59(10):1609-1615. PubMed ID: 29748235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.